Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | PSIP1 | O75475 | 1/20 | 0.34 |
| ▸ | CES2 | O00748 | 3/20 | 0.33 |
| ▸ | CES1 | P23141 | 3/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | ESR1 | P03372 | 2/20 | 0.32 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.32 |
| ▸ | KCNN4 | O15554 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17670017 | 0.86 | CES2 (0.37) | TDP1CYP3A4CES2CES1L3MBTL1 | |
| SCHEMBL28290968 | 0.85 | CES2 (0.39) | TDP1CYP3A4TP53CES2CES1 | |
| SCHEMBL27520003 | 0.83 | CES2 (0.41) | TDP1CES2CES1 | |
| SCHEMBL27484212 | 0.83 | CES2 (0.41) | TDP1CES2CES1 | |
| SCHEMBL9769194 | 0.83 | CES2 (0.41) | TDP1CES2CES1 | |
| SCHEMBL27411393 | 0.83 | CES2 (0.41) | TDP1CES2CES1 | |
| SCHEMBL27519999 | 0.83 | CES2 (0.41) | TDP1CES2CES1 | |
| SCHEMBL29184853 | 0.81 | CES2 (0.40) | TDP1CES2CES1 | |
| SCHEMBL2155208 | 0.80 | CYP3A4 (0.41) | TDP1CYP3A4TP53PSIP1CES2 | |
| SCHEMBL780436 | 0.77 | HTR7 (0.37) | TDP1LMNAL3MBTL1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103364989-A | Manufacturing method of color filter substrate | CPTW WUJIANG CO LTD | 2013-10-23 | — | — | CN | claimed |
| US-10479809-B2 | Method for producing alkenyl phosphorus compound | MARUZEN PETROCHEMICAL CO., LTD. (JP) | 2019-11-19 | — | — | US | disclosed |
| US-20190263847-A1 | METHOD FOR PRODUCING ALKENYL PHOSPHORUS COMPOUND | MARUZEN PETROCHEMICAL CO., LTD. (JP) | 2019-08-29 | — | — | US | disclosed |
| CN-108628000-A | Eye lens and preparation method thereof | 鸿富锦精密工业（深圳）有限公司 | 2018-10-09 | — | — | CN | disclosed |
| EP-3348561-A1 | METHOD FOR PRODUCING ALKENYL PHOSPHORUS COMPOUND | Maruzen Petrochemical Co., Ltd. (JP) | 2018-07-18 | — | — | EP | disclosed |
| CN-102675616-B | Phosphorus-containing flame retardant polyarylester and preparation method of phosphorus-containing flame retardant polyarylester | UNIV DONGHUA | 2013-10-30 | — | — | CN | disclosed |
| CN-103364989-A | Manufacturing method of color filter substrate | CPTW WUJIANG CO LTD | 2013-10-23 | — | — | CN | disclosed |
| US-7211603-B1 | Enediyne compounds and methods related thereto | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) | 2007-05-01 | — | — | US | disclosed |
| US-6987132-B1 | Enediyne compounds and methods related thereto | ADVANCED RESEARCH AND TECHNOLOGY INSTITUTE, INC. (US) | 2006-01-17 | — | — | US | disclosed |
| CN-1200943-C | Organometallic acyl-aryl phosphine | CIBA SC HOLDING AG (CH) | 2005-05-11 | — | — | CN | disclosed |
| US-6514995-B1 | Metal complex is capable of forming a benzenoid diradical under physiological conditions and/or under photothermal conditions | ADVANCED RESEARCH AND TECHNOLOGY INSTITUTE, INC. | 2003-02-04 | — | — | US | disclosed |
| CN-1308081-A | Organometallic acyl-aryl phosphine | CIBA SC HOLDING AG (CH) | 2001-08-15 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10479809-B2 | Method for producing alkenyl phosphorus compound | ORC3, OR10J3, ORAI3 | TDP1 3180/4885CYP3A4 53/4885TP53 3347/4885 |
| US-20190263847-A1 | METHOD FOR PRODUCING ALKENYL PHOSPHORUS COMPOUND | ORC3, OR10J3, ALK | TDP1 3486/4885CYP3A4 71/4885TP53 3581/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.